| Literature DB >> 33339328 |
Seyeon Oh1, Myeongjoo Son1,2, Chul-Hyun Park3, Ji Tae Jang4, Kuk Hui Son3, Kyunghee Byun1,2.
Abstract
In hyperlipidemia, pyroptosis in endothelial cells (ECs) induces atherosclerosis via the toll-like receptor 4 (TLR4) pathway. We evaluated the effects of Ecklonia cava extract (ECE) and pyrogallol-phloroglucinol-6,6-bieckol (PPB) on pyroptosis of ECs and vascular smooth muscle cells (VSMCs), which leads to attenuation of these cells and dysfunction of the aorta in high-fat-diet (HFD)-fed mice and in palmitate-treated ECs and VSMCs. The expression of TLR4 and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), which induce formation of NOD-LRR-and pyrin domain-containing protein 3 (NLRP3) inflammasomes, were increased by HFD and were decreased by ECE and PPB. The TLR4/NF-κB pathway was upregulated in palmitate-treated ECs and VSMCs and was decreased by ECE and PPB. The expressions of NLRP3/apoptosis-associated speck like protein containing a caspase recruitment domain, caspase-1, interleukin (IL)-1β, and IL-18 were increased by HFD and were decreased by ECE and PPB. Pyroptotic cells were increased by HFD and decreased by ECE and PPB. The expressions of the adhesion molecules, intercellular adhesion molecule and vascular cell adhesion molecule, and endothelin-1 were increased by HFD and were decreased by ECE and PPB. ECE and PPB decreased pyroptosis in the ECs and VSMCs, which was induced by HFD in the mouse aorta, and attenuated EC and VSMC dysfunction, an initiation factor of atherosclerosis.Entities:
Keywords: ecklonia cava; endothelial cells or vascular smooth muscle cells dysfunction; inflammasome; pyrogallol-phloroglucinol-6,6-bieckol; pyroptosis
Mesh:
Substances:
Year: 2020 PMID: 33339328 PMCID: PMC7766911 DOI: 10.3390/md18120648
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118